ABSTRACT
INTRODUCTION
Obesity is one of the fastestgrowing major diseases in many areas of the world. More than one half of United States men and women aged > 20 years are considered overweight and nearly one fourth are clinically obese (1) . Obesity results from an imbalance between energy intake and expenditure and it is closely associated with life-style-related diseases such as hyperlipidemia, hypertension, atherosclerosis and noninsulin-dependant diabetes mellitus and with increased risk of coronary heart disease (2) . Cardiovascular diseases constitute the main cause of morbidity and mortality in diabetes mellitus. Diabetic individuals have two-to four-folds increased risk of clinical atherosclerotic diseases. Dyslipidemia is proved to be the most modifiable risk factor contributing to atherosclerosis in diabetes. Furthermore, there is widespread acceptance of a possible generation of reactive oxygen species in diabetes as a result of hyperglycemia (3) . Active oxygen molecules have been demonstrated to play important role in the inflammation process and despite the presence of strong antioxidant defense mechanisms, the damage to DNA and other biomolecules accumulate during the lifetime of organism (4) . On the other hand, inflammation is associated with large range of mediators that initiate the inflammatory response, recruit and activate other cells to the site of inflammation and subsequently resolve the inflammation. In the presence of appropriate stimuli, gene expression and production of cytokine and reactant protein will occur, leading to the initiation of an inflammatory response (5) . The inability of the modern synthetic approach to provide a satisfactory answer has led to shift in focus to alternative forms of therapy based on drugs derived from plants. Herbs and spices are generally considered safe and proved to be effective against various human ailments (3,4). Ginger (Zingiber officinale Roscoe) is one of the most widely used spices and is reputed to have medical properties against many diseases. It contains several hundred valuable compounds and new constituents are still being found. The proportion of each in a sample of ginger depends upon country of origin, commercial processor and whether the ginger is fresh, dried or processed (6) . Pharmacologically, the plant has been investigated for its hypoglycemic, hypolipidemic, antimicrobial, antiinflammatory, antioxidant, and cytotoxic activities (3,7) .
Aim of the work:
The aim of the present study is to evaluate the beneficial effects of ginger in condition of hyperglycemia associated with hyperlipidemia and obesity and to investigate the effect of ginger as antioxidant and antiinflammatory agent.
MATERIALS & METHODS

Plant material: Dried Zingiber
(ginger) was purchased from a local market. It was give in a dose of about 500 mg/ kg orally added to the food. 2. Animals: The study was conducted on white adult female Wistar albino rats. Animals were obtained from the Animal House of Faculty of Medicine, Assiut University. Their weight ranged between 115-140 grams at the beginning of the experiment. They were housed in groups in standard environmental condition including good aerated room with suitable temperature. The experiment included 80 rats which were divided into 4 groups of 20 rats each. Group I (control group): rats received normal standard rodent food and water for 8 weeks were selected for the study as normal control.
Group II: rats were administered high fat diet composed of, corn oil 40 g/ 100g food, cornstarch 10g/100g food. Romy cheese 25 g/100 g food, sugar 9 g/100g food, casein 36g/100g food and vitamin and mineral mixture 1g/100g food (8) . This group was further divided into 2 subgroup each consisting of 10 rats. Group II (a) rats without ginger treatment and group II (b) rats with ginger treatment added to the diet in a dose of 500 mg/ kg body weight for 8 weeks. Group III: rats with Alloxan induced diabetes. 100 mg/kg of drug was injected intramuscularly in a single dose. The drug was dissolved in 0.5 ml saline and the animals were tested for diabetes after 5 days. The animals were considered diabetic when their blood glucose level was 300 mg/dl or more (9) .This group was further divided into 2 subgroups each consisting of 10 rats. Group III (a) rats without ginger treatment and group III (b) rats with ginger treatment for 8 weeks.
Group IV: rats with induction of inflammation. 0.1 ml of (0.5-2 %) of Carrageenin solution was injected into the planter surface of the right hind paw. Inflammation peak developed 24 hours after injection. To monitor the development of inflammation, planter circumference of the injected paw was measured (10) . Also, this group was divided into 2 subgroups each group consisting of 10 rats. Group IV (a) rats without ginger treatment and group IV (b) rats with ginger treatment for 8 weeks.
Blood collection and biochemical estimation:
At the end of the experiment, the animals of each group were sacrificed and blood was collected, centrifuged in 500 rpm for 15 minutes and the serum from each sample was kept at -20 ºC for determination of biochemical parameters.
Serum glucose was determined by the method of Weissman (11) . Serum total cholesterol and triglyceride were determined by the methods of Allian et al, (12) and McGowan et al, (13) respectively. Serum LDL-cholesterol and HDLcholesterol were determined by the methods of Assmann et al, (14) and Bergmenyer, (15) respectively. Nitric oxide was determined by the method of Buege and Aust, (16) . Also lipid peroxide was determined according to the method of Bezooijen et al, (17) . On the other hand, Prostaglandin E 2 (PGE 2 ) was determined by an ELISA kit for quantitative determination of prostaglandin E, Cat. No. KGE004 manufactured by R and D system Minneapolis, United States, America. The measurement was performed according to the method described by Brueggemeir et al, (18) . Also, Creactive protein (CRP) was determined by an ELISA kit for quantitative determination of Creactive protein. The kit was manufactured by DiaMed EuroGen, 2300 Turnhout, Belgium.
The measurement was performed according to the method described by Mitra and panja (19) .
Statistical analysis:
It was performed using SPSS statistical program (statistical package for social science, version 11) for analyzing the result data. All the studied parameters concentrations were presented as mean ± SD. The one way ANOVA was used to determine the significance of the difference between the groups. Student t-test was used to compare between two groups. P<0.05 was considered significant.
RESULTS
Rats of group II a (rats with high fat diet) showed significant increase in body weight, serum glucose, cholesterol, triglyceride, and LDLcholesterol levels and significant decrease in serum HDL-cholesterol levels as compared to group I (control group) (p< 0.0001 for each). Animals of group II (b) (rats treated with ginger) showed significant reduction in body weight and reduction in the serum level of glucose, cholesterol, triglyceride, and LDL-cholesterol and increase in the serum level of HDLcholesterol as compared with group II (a) (p<0.0001 for each) ( Table 1) .
Animals of group III (rats with alloxan induced diabetes) showed significant increase in blood glucose, cholesterol, triglyceride, LDLcholesterol levels and reduced serum level of HDL-cholesterol as compared with group I (p<0.0001). Animals of group III (b) (rats treated with ginger) showed significant reduction in serum levels of glucose, cholesterol, triglyceride, LDL-cholesterol and significant increase in serum level of HDL-cholesterol as compared with group III (a) ([<0.0001 for each) ( Table 2) .
Lipid peroxidation as reflected by lipid peroxide levels and nitric oxide levels were higher in group II (a) and group III (a) as compared with group I (p<0.0001 for each). Ginger supplementation caused significant reduction in the levels of lipid peroxide and nitric oxide as compared by group II (b) and group III (b) (p<0.0001 for each) ( Table 3) .
Animals of group IV (rats with carrageenin induced inflammation) showed significant increase in inflammatory markers 24 hours after injection of the drug as compared with group I (p<0.0001 for each). Animals with group IV (b) showed significant reduction in inflammatory markers as compared with group IV (a) (p<.0001 for each) (Table 4) . 
DISCUSSION
The inability of the modern synthetic approach to provide a satisfactory answer for treatment of several diseases has led to shift in focus to alternative forms of therapy based on drugs derived from plants. Zingiber officinal Roscore (ginger) is one of the most widely used spices and is reputed to have medical properties for treatment of arthritis, rheumatism, pains, constipation, vomiting, hypertension and infectious diseases (3,7) . Currently, there is a renewed interest in ginger, and several scientific investigations aimed at isolation and identification of active constituent of ginger, scientific verification of its pharmacological actions and of its constituents, and verification of basis of the use of ginger in some of several diseases (7) . The main pharmacological actions of ginger include anti-tumorigenic, antiinflammatory, ant-apoptotic, antihyperglycemic, anti-lipidemic and anti-emetic action. Ginger is strong anti-oxidant substance and may prevent generation of free radicals. It is considered a safe herbal medicine with only few and insignificant adverse effects (3), . In the present study, the rats taking high fat diet showed significant increase in weight and higher levels of glucose, cholesterol, triglyceride and LDL-cholesterol and reduction in HDL-cholesterol as compared with control group. Treatment with ginger to obese rats produced a significant reduction in weight and in the serum levels of glucose, cholesterol, triglyceride and LDL-cholesterol and increased serum level of HDLcholesterol. These results were in agreement with those of Goyal and Kadnur
(1) who found that treatment with methanolic and ethyl acetate extracts of ginger to obese mice, produced a significant reduction in serum glucose levels and reduction in elevated lipid levels associated with hyperglycemia and hyperinsulinemia. Also, Han et al, (2) reported that body weight was significantly lowered in mice fed with the high fat diet containing 3% aqueous extract of ginger than in the controls fed with the high fat diet. In addition, Thomson et al. (20) , Verma et al. (21) , and Nicoll and Henein, (6) reported that in animals which were diabetic or have fed a high lipid diet, ginger significantly lowered serum total cholesterol, LDL, VLDL, triglyceride and phospholipids. Also there were significant reduction in atherosclerotic lesions and associated foam cell formation and raised HDL as effectively as conventional hypolipidemic drugs.
5-hydroxytryptamine (5-HT) receptor modulators were reported to have beneficial effects in condition of obesity. It plays a crucial role in controlling appetite; hence drugs modulating 5-HT function and thereby controlling the appetite are useful in conditions of obesity. Ginger is reported to contain 5-HT modulators and its effects in reducing elevated glycemic and lipid levels and reduction in body weight may be due to its 5-HT modulatory effects
(1) . On the other hand, Han et al.
(2) suggested that the anti-obesity effect of aqueous extract of ginger may be due in part to the inhibition of intestinal absorption of dietary fat by the active compounds of ginger.
The present study was to investigate the effect of ginger on diabetic dyslipidemia induced by alloxan in rats. The study revealed the significant anti-hyperglycemic activity of ginger. Furthermore, treatment with ginger also produced significant reduction in serum cholesterol, triglyceride and LDL-cholesterol. These results were in agreement with the results of Bhandari et al.
(3) who found that ethanolic extract of ginger reduced glucose and lipid levels indicating the hypoglycemic and lipid lowering activity of the tested drug. Also, Al-Amin, et al. (22) reported that diabetic rats showed significant increase in serum levels of glucose, cholesterol and triglycerides. They also, reported that an aqueous extract of raw ginger effectively lowers serum glucose, cholesterol and triglyceride levels in diabetic rats. A similar result was reported by Akhani et al.
(23) , Kadnur and Goyal (24) , Ojewole (25) and Nicoll et al. (6) . In contrast, in another study, nondiabetic patients with coronary artery diseases showed no decrease in their blood lipid or sugar levels when treated with a daily dose of 4 g powdered ginger for a period of 3 month (26) . Aldose reductase inhibitors are now considered to have remarkable potential for treatment of diabetes and its complications without increased risk of hypoglycemia. It has recently been reported that the assay for aldose reductase inhibitors in ginger led to isolation of five active compounds including 2-(4-hydroxy-3-methoxyphenyl) ethanol and 2-(4-hydroxy-3-methoxyphenyl) ethanoic acid. These tow compounds were good inhibitors of recombinant human aldose reductase (7) . Furthermore, these compounds significantly suppressed not only sorbitol accumulation in human erythrocytes, but also lens galactitol accumulation in 30% of galactose-fed cataract rats, suggesting that protection against or improvement of diabetic complication could be achieved with dietary supplement of either ginger or extract containing aldose reductase inhibitors (7) . Al-Amin et al. (22) reported that the hypoglycemic action of ginger may be due to effects involving serotonin receptors, an increased in pancreatic secretion of insulin from B cells or release of bound insulin. In addition Verma et al. (21) and Nicoll and Henein (6) reported that ginger acts on the liver to reduce cholesterol biosynthesis and may stimulate cholesterol conversion to bile acids and increased its fecal excretion.
In the present study, rats taking high fat diet and animals with alloxan induced diabetes showed significant increase in nitric oxide and lipid peroxide. Treatment with ginger to these two groups led to significant decrease in the levels of nitric oxide and lipid peroxide. These results were in agreement with those of Lppoushi et al. (27) and Bhandari et al. (3) showed that an addition of aqueous extract of ginger to the p-hydroxybenzoic acid induced lipid peroxidation significantly reduced this lipid peroxidation. In addition, Suganthi et al. (30) found that administration of spices mixture including ginger along with fructose diet reduced the levels of peroxidation markers in tissues and improved the antioxidant status and the positive effects on oxidant-antioxidant balance. This could be attributed to the active constituents of ginger. Recently, it has been showed that 6-gingerol is endowed with strong antioxidant action both in vivo and vitro and this makes it a very effective agent for prevention of ultra violetinduced reactive oxygen species production (31) . In the present study, rats with carrageenin induced inflammation showed significant increase in the levels of inflammatory mediator as prostaglandin E 2 and C-reactive protein. Treatment with ginger to this group showed significant decrease in the levels of inflammatory mediator. These results were in agreement with de Lemos et al.
(32) who found that Creactive protein was increased in a condition of low grade systemic inflammation as in cardiovascular diseases and type 2 diabetes. Also, Amezcua-Guerra et al.
(33) showed that C-reactive protein is a non specific acute phase protein that has been used as inflammatory marker and increased level of it cause induction of cytokines and prothrombotic factors. C-reactive protein did not alter endothelial nitric oxide synthase protein expression but increased protein expression of GTP cyclohydrolase-1, the rate limiting enzyme in the synthesis of tetrahydrobiopterin, the nitric synthase cofactors (34) . In addition, Thomson et al. (20) and Ojewole, (25) confirmed the inhibitory action of ginger on prostaglandins when they reported that either oral or intraperitoneal administration of ginger (500 mg) given to rats daily for 4 weeks was effective in significantly reducing serum prostaglandin. Grzanna et al. (35) showed that ginger and some of its constituents is effective against cytokines synthesized and secreted at the site of inflammation and it was found to inhibit the induction of several genes involved in the inflammatory response and can inhibit beta-amyloid peptide-induced cytokines and chemokines expression. He also reported that ginger shares pharmacological properties with nonsteroidal anti-inflammatory drugs through suppression of prostaglandin biosynthesis by inhibiting cyclooxygenase-1 and cyclooxygenase-2.
Ginger also suppresses leukotriene biosynthesis by inhibiting 5-lipoxygenase enzyme and these observations may have better therapeutic profile and fewer side effects than non steroidal antiinflammatory drugs (35) . Also, Lantz et al. (5) found that organic extract of ginger and compounds found in ginger are highly effective in inhibit lipopolysaccharides-induced production of prostaglandins E2 and these compounds appear to be not only inhibit cyclo-oxygenase-2 enzyme activity, but are also able to alter cyclo-oxygenase-2 mRNA levels. In addition, Tripathi et al. (36) showed that ginger not only inhibit proinflammatory cytokine production by macrophages but also decreased production of pro inflammatory mediators.
In conclusion the present data suggest that ginger has potential beneficial effects in condition of obesity, hyperglycemia and hyperlipidemia. In addition to decrease serum level of glucose and lipid, ginger can also significantly retard gain in body weight. Based on these beneficial effects, ginger can be considered as supplementary herbal therapy for prevention and treatment of obesity, treatment of diabetes and hyperlipidemia. Also ginger has antiinflammatory effects and can protect tissues from lipid peroxidation. Taken together, these results suggest that ginger has potent antioxidant and antiinflammatory potentials, and may be a promising candidate in prevention and or therapy for inflammation associated carcinogenesis. Further study is needed to investigate the active compounds of ginger responsible for the observed beneficial effects. 
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